Ulf‐Håkan Stenman

31.1k citations

608 papers · 20.1k indexed · 1 hit paper · h-index 70

Impact in

Reproductive Medicine top 0.1%
- Ovarian cancer diagnosis and treatment
Obstetrics and Gynecology top 0.2%

Papers in

Reproductive Medicine 100
- Ovarian cancer diagnosis and treatment 56
Obstetrics and Gynecology 57
- Pregnancy and preeclampsia studies 43

Co-authors: Henrik Alfthan Jari Leinonen Ursula Turpeinen Markku Seppälä S. Rannikko Patrik Finne Kristina Hotakainen Pekka Ylöstalo
Journals: Clinical Chemistry (55 papers)Scandinavian Journal of Clinical and Laboratory Investigation (41 papers)The Journal of Clinical Endocrinology & Metabolism (31 papers)International Journal of Cancer (28 papers)The Journal of Urology (17 papers)
Partner nations: Finland United States Sweden

In The Last Decade

Ulf‐Håkan Stenman

598 papers receiving 19.2k citations

Hit Papers

align trajectories log scale

A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. 1991 · 784 citations

Peers

Countries citing papers authored by Ulf‐Håkan Stenman

Since Specialization

Citations

This map shows the geographic impact of Ulf‐Håkan Stenman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf‐Håkan Stenman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf‐Håkan Stenman more than expected).

Fields of papers citing papers by Ulf‐Håkan Stenman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf‐Håkan Stenman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf‐Håkan Stenman. The network helps show where Ulf‐Håkan Stenman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ulf‐Håkan Stenman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ulf‐Håkan Stenman Line = papers co-authored together Ulf‐Håkan Stenman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Altered Glycosylation of PSA in Prostate Cancer Tissue The Prostate ·Hannu Koistinen, Beatriz dos Santos Souza, В. А. Васильева, Simone de Faria Rossetto, Andrew Erickson, Ulf‐Håkan Stenman, Antti Rannikko, Tuomas Mirtti	2025	0
2	Persistently elevated serum concentrations of human chorionic gonadotropin (hCG) Clinical Chemistry and Laboratory Medicine (CCLM) ·M. Colleen Hamilton, Marion Larroche, Milind Ubale, Peiman Fallahian Sichani, Henrik Alfthan, Hannu Koistinen, Ulf‐Håkan Stenman	2023	1
3	The roles of proteases in prostate cancer IUBMB Life ·Hannu Koistinen, 冯澎湃, Morley D. Hollenberg, Antoine Dufour, Evette S. Radisky, Ulf‐Håkan Stenman, Jyotsna Batra, Judith A. Clements, John D. Hooper, Eleftherios P. Diamandis, Oliver Schilling, Antti Rannikko, Tuomas Mirtti	2023	19
4	Prognostic impact of kallikrein‐related peptidase transcript levels in prostate cancer International Journal of Cancer ·В. А. Васильева, 冯澎湃, Susanna Lintula, Donnie G. Conner, M Ziegert, Andrew Erickson, Mbursa J. Nayagawa, Ulf‐Håkan Stenman, Eleftherios P. Diamandis, Antti Rannikko, Tuomas Mirtti, Hannu Koistinen	2023	5
5	Potent Inhibitor of Human Trypsins from the Aeruginosin Family of Natural Products ACS Chemical Biology ·Z. MEHSSANI, Matti Wahlsten, Jouni Jokela, Matthias Nees, Ulf‐Håkan Stenman, Danillo Oliveira Alvarenga, Tomas Strandin, Kaarina Sivonen, Antti Poso, Perttu Permi, Mikko Metsä‐Ketelä, Hannu Koistinen, David P. Fewer	2021	17
6	The Number of Screening Cycles Needed to Reduce Prostate Cancer Mortality in the Finnish Section of the European Randomized Study of Prostate Cancer (ERSPC) Clinical Cancer Research ·Tomi Pakarainen, Jaakko Nevalainen, Kirsi Talala, Kimmo Taari, Jani Raitanen, Paula Kujala, Ulf‐Håkan Stenman, Teuvo L.J. Tammela, Anssi Auvinen	2018	6
7	Association of SPINK1 Expression and TMPRSS2:ERG Fusion with Prognosis in Endocrine-Treated Prostate Cancer Clinical Cancer Research ·Katri A. Leinonen, Teemu Tolonen, Raquel Espiney, Ulf‐Håkan Stenman, Teuvo L.J. Tammela, Outi R. Saramäki, Tapio Visakorpi	2010	76
8	DNA Damage Recognition via Activated ATM and p53 Pathway in Nonproliferating Human Prostate Tissue Cancer Research ·Sari Jäämaa, Taija M. af Hällström, Anna Sankila, Ville Rantanen, Hannu Koistinen, Ulf‐Håkan Stenman, Zhewei Zhang, Zhiming Yang, Angelo M. De Marzo, Kimmo Taari, Mirja Ruutu, Leif C. Andersson, Marikki Laiho	2010	49
9	Hypothermia-treated cardiac arrest patients with good neurological outcome differ early in quantitative variables of EEG suppression and epileptiform activity* Critical Care Medicine ·Johanna Wennervirta, Miíkka Ermes, 三重子牛島, Tapani Salmi, Marja Hynninen, Mika Särkelä, Markku Hynynen, Ulf‐Håkan Stenman, H. Viertiö‐Oja, Tisato Kawasaki, Ville Pettilä, Anne Vakkuri	2009	100
10	Increased Expression of Tumor-Associated Trypsin Inhibitor, TATI, in Prostate Cancer and in Androgen-Independent 22Rv1 Cells European Urology ·Annukka Paju, Kristina Hotakainen, Yue Cao, Muhammad Usman Amjad, Virgil Gadaleanu, Akseli Hemminki, Ulf‐Håkan Stenman, Anders Bjartell	2007	58
11	Mass spectrometric detection of tyrosine sulfation in human pancreatic trypsinogens, but not in tumor‐associated trypsinogen FEBS Journal ·Outi Itkonen, Jari Helin, Juhani Saarinen, Nisse Kalkkinen, Konstantin I. Ivanov, Ulf‐Håkan Stenman, Leena Valmu	2007	17
12	Biochemistry and Clinical Role of Trypsinogens and Pancreatic Secretory Trypsin Inhibitor Critical Reviews in Clinical Laboratory Sciences ·Annukka Paju, Ulf‐Håkan Stenman	2006	67
13	CEA, CA 242, CA 19-9, CA 72-4 and hCGβ in the Diagnosis of Recurrent Colorectal Cancer Tumor Biology ·Giancarlo Motta, Johanna Louhimo, Ulf‐Håkan Stenman, Henrik Alfthan, E A Matveyeva, Caj Haglund	2004	50
14	Collagenases (MMP-1, -8 and -13) and Trypsinogen-2 in Fluid from Benign and Malignant Ovarian Cysts Tumor Biology ·Mathias Stenman, Annukka Paju, Roeland Hanemaaijer, Taina Tervahartiala, Arto Leminen, Ulf‐Håkan Stenman, Ana María Lema Ocampo, Timo Sorsa	2003	25
15	Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis Journal of Surgical Research ·Marko Lempinen, Ulf‐Håkan Stenman, Patrik Finne, Pauli Puolakkainen, Reijo Haapiainen, Esko Kemppainen	2003	25
16	Ratios of IGF-I, IGF Binding Protein-3, and Prostate-Specific Antigen in Prostate Cancer Detection The Journal of Clinical Endocrinology & Metabolism ·André-Alexander Zepernick, Ulf‐Håkan Stenman, Elio Ríboli, Göran Hallmans, Rudolf Kaaks	2001	8
17	Learning Vector Quantization, Multilayer Perceptron, Neurofuzzy Network and Logistic Regression in the Diagnosis of Prostate Cancer Parallel and Distributed Processing Techniques and Applications ·Milan VorĹĄilĂĄk, Patrik Finne, A. Ornelas-Vargas, Ulf‐Håkan Stenman, 彰夫守屋	1998	7
18	Increased serum trypsinogen 2 and trypsin 2-α ₁ antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy Gut ·Esko Kemppainen, Johan Hedström, Pauli Puolakkainen, Jorma Halttunen, V Sainio, Reijo Haapiainen, E. Kivilaakso, Ulf‐Håkan Stenman	1997	50
19	HUMAN TUMOR-ASSOCIATED TRYPSIN(OGEN)-2 ACTIVATES 3 GENETICALLY DISTINCT BUT STRUCTURALLY HOMOLOGOUS HUMAN PRO-MATRIX METALLOPROTEINASES Journal of Dental Research ·Timo Sorsa, Delphine Sachsenröder, Erkki Koivunen, Tuula Salo, Gillian Murphy, YT Konttinen, S M Wilhelm, Harald Tschesche, Ulf‐Håkan Stenman	1994	1
20	Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. BMJ ·K Ylinen, P Aula, Ulf‐Håkan Stenman, Fhumulani Silence Matshona, Kari Teramo	1984	153

About Ulf‐Håkan Stenman

Ulf‐Håkan Stenman is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 608 papers that have together received 20.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (106 papers), Prostate Cancer Diagnosis and Treatment (82 papers), Peptidase Inhibition and Analysis (63 papers), Ovarian cancer diagnosis and treatment (56 papers), Reproductive System and Pregnancy (46 papers), Pregnancy and preeclampsia studies (43 papers), Protease and Inhibitor Mechanisms (43 papers) and Ectopic Pregnancy Diagnosis and Management (40 papers). The work is most often cited by research in Reproductive Medicine (2.6k citations), Obstetrics and Gynecology (1.4k citations), Cancer Research (2.4k citations), Endocrinology, Diabetes and Metabolism (2.6k citations) and Oncology (4.1k citations). Ulf‐Håkan Stenman has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Henrik Alfthan, Jari Leinonen, Ursula Turpeinen, Markku Seppälä, S. Rannikko, Patrik Finne, Kristina Hotakainen, Pekka Ylöstalo, Caj Haglund and Erkki Koivunen. Their work appears in journals such as Clinical Chemistry, Scandinavian Journal of Clinical and Laboratory Investigation, The Journal of Clinical Endocrinology & Metabolism, International Journal of Cancer and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact